PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A ...
May 1, 2011, 00:00
10.1016/j.jval.2011.02.859
https://www.valueinhealthjournal.com/article/S1098-3015(11)00998-3/fulltext
Title :
PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00998-3&doi=10.1016/j.jval.2011.02.859
First page :
A154
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
324